Last updated: 2026-10-13 23:05:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
LENSAR, Inc. (LNSR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $6.32, with a market capitalisation of $78.26M and a P/E ratio of 4.93. Over the past 52 weeks, its price has ranged from $4.95 to $12.94. This page covers its latest market performance, valuation, price trends and company information.
$78.26M | |
$6.21 | |
$17.31 | |
$1.80 | |
$6.22 | |
22.75K | |
103.54K | |
4.93 | |
$12.94 | |
$4.95 | |
-- | |
-- |
LENSAR, Inc. (LNSR) is trading at $6.25 in after-hours trading as of 2026-10-13 23:01:00, up 0.42% ($0.03) from the regular-session close of $6.22.
After-hours trading shows how investors are pricing LNSR after the regular session closes. The current after-hours price is near the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, LENSAR, Inc. (LNSR) moved from $6.75 to $6.32, representing a decline of 6.44% ($0.43).
The stock traded between $6.17 and $6.87 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 38.78 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 17.1%
LNSR is currently trading at $6.32, placing it 17.1% of the way from its 52-week low of $4.95 to its 52-week high of $12.94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 150 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of LENSAR, Inc. (LNSR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.